Seminars in Oncology

Papers
(The median citation count of Seminars in Oncology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Clinical efficacy and security analysis of DEB-TACE combined with trans arterial infusion of carrelizumab in the therapy of advanced liver cancer71
Breaking barriers: Deciphering the mechanisms of Olaparib resistance in prostate cancer62
Pretreatment eosinophilia as a biomarker for adverse outcomes in non-small cell lung cancer patients receiving immune checkpoint inhibitors: A systematic review and meta-analysis31
Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis31
Unlocking the therapeutic potential of polyphenols: Promising advances and future directions in pancreatic cancer treatment26
Masthead22
Integrated analysis of scRNA-seq and bulk RNA-seq data identifies BHLHE40 as a key gene in pancreatic cancer progression and gemcitabine resistance22
Overexpression of CAD in stomach adenocarcinoma tissues and its clinical significance20
Table of Contents20
Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review20
Deciphering the US Regulatory Framework: Comparison Between Oncology Biosimilars and Reference Biologics19
Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans19
Role of neoadjuvant pembrolizumab in advanced melanoma17
Editorial Board16
Psoas muscle depletion correlates with poor prognosis and compromised immunity in resectable gastric cancer: A multicenter study15
Military exposures and lung cancer in United States Veterans15
Explainable machine learning and feature interpretation to predict survival outcomes in the treatment of lung cancer14
Editorial Board13
Adenocarcinoma on retrorectal cystic hamartoma: An illustrative image for a very rare diagnosis13
Editorial Board13
Masthead11
Assessment of PSA responses and changes in the rate of tumor growth -rate with immune checkpoint inhibitors in US Veterans with prostate cancer11
Advancing personalized medicine in LMICs: Predictive indicators for cervical cancer immunotherapy response11
Editorial Board11
Impact of the COVID-19 Pandemic on the Wellbeing of International Oncology and Hematology Fellows at the Princess Margaret Cancer Center (PMCC)10
Masthead10
The interest of therapeutic and pharmacological drug monitoring of methotrexate: A systematic review10
Editorial Board10
Genome editing of immune checkpoints: CRISPR-mediated PD-1 inhibition in cancer10
Masthead10
Prostate cancer: Evolution of multiparametric MRI PI-RADS v2.1 toward biparametric MRI S-PI-RADS10
Role of Magnolol in gastrointestinal cancers: recent trends and future perspectives9
Acute liver failure secondary to malignant infiltration: A single center experience9
The nervous system in prostate cancer: A basic science and clinical perspective9
Lactylation in radiosensitivity regulation: Mechanistic insights and recent advances9
Breast cancer exosomes: Managing macrophage polarization and immune regulation in the tumor microenvironment8
Mapping the epidemiology of cancer-related anemia: A systematic scoping review of global prevalence and incidence8
The effects of microbiota-derived short-chain fatty acids on T lymphocytes: From autoimmune diseases to cancer8
Hexokinases in gastrointestinal cancers: From molecular insights to therapeutic opportunities8
Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world population7
Biomarkers and the microbiome in the detection and treatment of early-stage non-small cell lung cancer7
Screening Adherence for Second Primary Malignancies in Breast Cancer Survivors: Behaviors, Facilitators, and Barriers to Enhance Quality Care7
Editorial Board7
Surgery for early-stage lung cancer with video-assisted thoracoscopic surgery versus open thoracotomy: A narrative review7
The challenges of selecting cancer medicines for the WHO Essential Medicines List with the elephant in the room: A path forward7
A narrative review of the principal glucocorticoids employed in cancer6
Barriers and facilitators to lung cancer screening and follow-up6
Masthead6
MicroRNAs: From Bench to Bedside Applications as Breast Cancer Therapeutics6
Multiple myeloma: Insights into underlying mechanisms, advances in diagnostic and therapeutic modalities6
Tumor tough, therapy smarter: Rethinking CAR-T for pancreatic cancer5
High tumor mutation burden mitigates the negative impact of chemotherapy history on immune checkpoint blockade therapy5
Recent updates on novel heterocyclic scaffolds of anticancer potential as emerging tubulin inhibitors5
Exosomal circular RNAs as drivers of temozolomide resistance in glioblastoma: Mechanisms and implications5
Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspects5
Colorectal cancer in Ethiopia: Epidemiological trends, diagnostic and laboratory capacities, and challenges5
outside front cover5
Risk of Intensive Care Unit Admission after Immune Checkpoint Inhibitor Use in Cancer5
Treating advanced lung cancer in older Veterans with comorbid conditions and frailty4
Masthead4
Baicalein and baicalin in cancer therapy: Multifaceted mechanisms, preclinical evidence, and translational challenges4
Editorial Board4
Unveiling the role of RAI14 in cancer: Biological significance and translational perspectives4
Masthead4
Metabolism at the core of melanoma: From bioenergetics to immune escape and beyond4
Advances and challenges in cancer immunotherapy: Strategies for personalized treatment4
Are we there yet? Gut microbiota for cancer diagnosis, prognosis and treatment4
Cancer genetic mutation prevalence in sub-Saharan Africa: A review of existing data4
TOC3
Outside front cover3
PARP inhibitors in ovarian cancer3
outside front cover3
Comparative efficacy of osimertinib with and without radiation therapy in EGFR-mutated nonsmall cell lung cancer with brain metastases3
CDK4/6 inhibitors in the treatment of metastatic breast cancer: Focus on toxicity and safety3
Table of Contents3
Physics-Informed Machine Learning for Tumor Microenvironment-Responsive Nanomedicine: Recent Updates3
Table of Contents3
Table of Contents3
Table of Contents3
Masthead3
UBE2T promotes papillary thyroid carcinoma progression by activating the JAK/STAT3 pathway via negative regulation of SOCS23
Assessing Outcomes in NSCLC: Radiomic analysis, kinetic analysis and circulating tumor DNA3
Evaluating the Ability of Generative AI to Standardize TNM Staging Data in Lung Cancer3
Masthead3
Comorbidity and life expectancy in shared decision making for lung cancer screening3
Prostate cancer in Türkiye: Trend analysis of incidence and mortality rates3
Masthead3
Outcomes with panobinostat in heavily pretreated multiple myeloma patients3
Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review2
Divergent functions of TLRs in gastrointestinal (GI) cancer: Overview of their diagnostic, prognostic and therapeutic value2
The dual effect of interferon-γ in acute myeloid leukemia: A narrative review2
Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias2
Editorial Board2
TOC2
Fingerprint change as a consequence of anticancer treatments: A systematic integrative review2
Efficacy of metformin drug in preventing metabolic syndrome associated with androgen deprivation therapy (ADT) in prostate cancer patients: A systematic review and meta-analysis2
outside front cover2
Table of Contents2
The critical role of NLRP3 in drug resistance of cancers: Focus on the molecular mechanisms and possible therapeutics2
The Crucial Nexus: Unveiling the Role of Collagen in Cancer Progression2
Masthead2
Outside front cover2
Lung cancer screening at the VA: Past, present and future2
Which future for de-intensified treatments in HPV-related oropharyngeal carcinoma?2
Targeting TRP channels in oral cancer: Mechanistic potential and therapeutic promise2
Editorial Board2
The role of circular RNAs in driving cancer advancement in low-oxygen conditions2
Epidemiology and prevention of gastric cancer: A comprehensive review1
Tumor testing and treatment patterns in veterans with metastatic castration-resistant prostate cancer1
Deciphering autophagy signaling in cancer: A paradigm shift from molecular classifications to clinical innovations1
Bleeding risk with concomitant administration of VEGF-TKIs and anticoagulant agents1
Immune-checkpoint inhibitors in anal squamous cell carcinoma: a systematic review and meta-analysis1
TOC1
Submicron silica particles drives prostate cancer aggressiveness via lipid-metabolic reprogramming1
Lung Cancer Screening and Precision Oncology1
Deciphering the prognostic value and immunotherapeutic strategy of aggrephagy in melanoma: Integrating single-cell sequencing and machine learning1
Masthead1
Immuno-oncology approaches to overcome T cell exhaustion in melanoma1
Lung cancer: Premalignant biology and medical prevention1
Outside front cover1
TOC1
Advances in the management of metastatic lobular breast cancer: Current evidence and emerging treatments1
Machine learning-based integration develops a lactate metabolism related gene signature for improving outcomes in pancreatic ductal adenocarcinoma1
TOC1
Editorial Board1
Overcoming barriers to opioid-induced constipation management in cancer patients1
Non-small cell lung cancer in the era of immunotherapy1
Epidemiology and genetics of early onset colorectal cancer—African overview with a focus on Ethiopia1
Table of Contents1
Deregulated cell cycle control: The interplay between non-coding RNAs and cyclin-dependent kinases in tumorigenesis1
Table of Contents1
0.091015100479126